PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Expand the UK's COVID-19 symptom list to prevent cases being missed, say experts

Official signs of fever, cough, and loss of smell or taste too narrow to spot milder cases

2021-07-01
(Press-News.org) Expanding symptom list in line with other countries could improve the UK's pandemic response The UK should expand its official list of symptoms for defining covid-19 to prevent cases being missed and help improve the UK's pandemic response, say experts in The BMJ today.

They argue that limiting symptomatic testing to those with these official symptoms "will miss or delay identification of many covid-19 cases, hampering efforts to interrupt transmission."

During the covid-19 pandemic the British public has been told to self-isolate and get a test if they have a high fever, a new continuous cough, or a loss or change to their sense of smell or taste.

But Alex Crozier at University College London and colleagues say many people don't have these official symptoms, initially, or ever, and other symptoms often manifest earlier

They point out that the The World Health Organization and Centers for Disease Control and Prevention already include nine and 11 more case defining symptoms, respectively, than the UK. And the European Centre for Disease Prevention and Control describe a breadth of symptoms associated with mild-to-moderate covid-19, the most commonly reported being headache, weakness or tiredness, muscle aches, runny nose, appetite loss and sore throat.

These unofficial symptoms are also more common in young unvaccinated, or partially vaccinated people, who are most likely to pass the virus on.

It seems counterintuitive, therefore, to have no official UK guidance on wider covid-19 symptoms, or to offer different testing routes for those with official symptoms and those with no symptoms, with nothing in between, they write.

They acknowledge that expanding the case definition is likely to increase demand for testing and numbers self-isolating, and would require careful implementation.

However, new data suggests that testing people based on combinations of unofficial and official symptoms could be used to help identify more cases sooner without overwhelming testing capacity.

Vaccinations alone are unlikely to end the pandemic, they write. New, more transmissible and (partially) vaccine resistant variants may spread through susceptible populations causing high hospitalisation rates.

Inequalities in vaccination are also shifting the burden of disease and disruption to the most disadvantaged communities, who are also harmed most by covid-19 restrictions, they add.

"To reopen society with greater speed and fairness, control of transmission must improve. This starts with an expanded and more context appropriate case definition and rests on adaptive, locally grounded, and information-led public health responses," they conclude.

INFORMATION:

Externally peer reviewed? Yes
Evidence type: Data Analysis; Opinion
Subject: Covid-19 symptoms



ELSE PRESS RELEASES FROM THIS DATE:

Diet rich in omega 3 fatty acids may help reduce headaches

2021-07-01
Eating a diet rich in omega 3 (n-3) fatty acids reduces the frequency of headaches compared with a diet with normal intake of omega 3 and omega 6 (n-6) fatty acids, finds a study published by The BMJ today. Modern industrialised diets tend to be low in omega 3 fatty acids and high in omega 6 fatty acids. These fatty acids are precursors to oxylipins - molecules involved in regulating pain and inflammation. Oxylipins derived from omega 3 fatty acids are associated with pain-reducing effects, while oxylipins derived from omega 6 fatty acids worsen pain and can provoke migraine. But previous studies evaluating omega 3 fatty acid supplements for migraine have been inconclusive. So a team of US researchers wanted to find out whether diets ...

Diet with more fish fats, less vegetable oils can reduce migraine headaches

Diet with more fish fats, less vegetable oils can reduce migraine headaches
2021-07-01
A diet higher in fatty fish helped frequent migraine sufferers reduce their monthly number of headaches and intensity of pain compared to participants on a diet higher in vegetable-based fats and oils, according to a new study. The findings by a team of researchers from the National Institute on Aging (NIA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), parts of the National Institutes of Health; and the University of North Carolina (UNC) at Chapel Hill, were published in the July 3 issue of The BMJ. This study of 182 adults with frequent migraines ...

Study identifies existing drugs that could be repurposed to treat gonorrhea

2021-07-01
New research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) being held online (9-12 July) identifies drugs that could potentially be repurposed for the treatment of gonorrhoea (Neisseria gonorrhoeae [Ng]): a sexually transmitted infection which is becoming increasingly resistant to existing antibiotics. The decreased susceptibility of the Ng bacterium to extended spectrum cephalosporin antibiotics has become an important public health issue as cases of this common infection become more difficult to treat. The study ...

Study links mental health with risk of tuberculosis

2021-07-01
New research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) taking place online (9-12 July) shows that individuals affected by mental illnesses including depression and schizophrenia experience an increased incidence of tuberculosis (TB). TB and mental illnesses are both urgent global health priorities with a high prevalence across the world, and often co-exist. Although poor mental health is known to affect the immune system, it is not known whether mental illness plays a causal role in TB infection ...

Study suggests it is common for pet dogs and cats to catch COVID-19 from their owners

2021-07-01
COVID-19 is common in pet cats and dogs whose owners have the virus, according to new research being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) held online this year. Cases of owners spreading the disease to their dog or cat have been documented before but are considered to be of negligible risk to public health. However, as vaccination and other measures reduce human-to-human transmission of the virus, it is becoming imperative that we understand more about the potential risk posed by animal infections. To find out more, Dr Els Broens ...

Cats may catch COVID-19 from sleeping on their owner's bed

2021-07-01
**Note this is a special early release from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2021). Please credit the conference if you use this story** New research being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held online this year, suggests that people with COVID-19 frequently pass it on to their pets. Cats that sleep on their owner's bed seem to be at particular risk of infection. Previous studies have shown that cats and dogs can catch COVID-19 from their owners but it wasn't clear how susceptible they were and what, if anything, increased their odds of becoming infected. Answering these questions is important from both a public health and animal ...

COVID-19 vaccine reduces severity, length, viral load for those who still get infected

2021-07-01
Individuals who contract COVID-19 even after vaccination are likely to have a lower viral load, experience a shorter infection time and have milder symptoms than people who are unvaccinated, according to research that includes data from ongoing University of Arizona Health Sciences studies. "If you get vaccinated, about 90% of the time you're not going to get COVID-19," said Jeff Burgess, MD, MS, MPH, associate dean for research and professor at the Mel and Enid Zuckerman College of Public Health and principal investigator of the Arizona Healthcare, ...

Are multiple sclerosis drugs used early on in the disease also effective later?

2021-06-30
MINNEAPOLIS - Finding treatments for advanced multiple sclerosis (MS) has been difficult. But new research may help neurologists identify which drugs are best for people with the advanced form of MS called secondary progressive MS. The new study, published in the June 30, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology, found that the more potent disease-modifying drugs are more effective in reducing flare-ups in secondary progressive MS than the less potent drugs that tend to be safer to take. However, the researchers found no difference in how fast the disease progressed between these two types of drugs. Most ...

Does socioeconomic status explain why Black people with MS have more disability?

2021-06-30
MINNEAPOLIS - A new study suggests that even when differences in socioeconomic status are taken into consideration, Black people with multiple sclerosis (MS) may be more negatively impacted by the disease than white people with MS. The research is published in the June 30, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study found that Black people with MS had lower scores on certain measures of neurological health, like dexterity and walking tests and showed more evidence of disease progression on brain scans. "While lower socioeconomic status appears to be linked to doing worse on tests ...

Did your plastic surgeon really turn back the clock? Artificial intelligence may be able to quantify how young you actually look after facelift surgery

2021-06-30
June 30, 2021 - For most patients, the reasons for having a facelift are simple: to "turn back the clock" for a younger and more attractive appearance. Even during the pandemic year 2020, more than 234,000 patients underwent facelift surgery, according to American Society of Plastic Surgeons (ASPS) statistics. When considering facelift surgery, patients may ask, "How much younger will I look?" For plastic surgeons, that has been a difficult question to answer. Typically, the cosmetic outcomes of facelifting have been judged on a case-by-case basis, or with the use of subjective ratings. Now research suggests a new, objective approach to assessing the reduction in apparent age after facelift surgery: artificial intelligence (AI) networks trained to estimate age based on facial ...

LAST 30 PRESS RELEASES:

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

[Press-News.org] Expand the UK's COVID-19 symptom list to prevent cases being missed, say experts
Official signs of fever, cough, and loss of smell or taste too narrow to spot milder cases